FDA approval of pembrolizumab from KN671
Daniel Ahn
Share Talk
October 17, 2023
6 hr
Default user image
Log in Sign Up
Channels
DiscoveryCardiology
Every Day
COVID
Every Day
Dermatology
Every Day
Endocrinology
Every DayENDO 2022ATA 2022
Gastroenterology
Every DayIBS
Hematology
Every DayMiracles For MyelomaASH 2024
Hepatology
Every Day
Nephrology
Every DayASN 2024Kidney Week 2022NKF SCM 22
Oncology
Every DayGastrointestinalHER2+ @ ASCO 2025ESMO 2022
Ophthalmology
Every DayAMDDry Eye DiseaseARVO 2024VISIONS 2024AAO 2023WIO 2022
Primary Care
Every Day
Pulmonology
Every Day
Rheumatology
Every DayHIVACR 2024
Urology
Every Day
Speaker
Talk's display image
FDA approval of pembrolizumab from KN671